MASS stock icon

908 Devices

3.43 USD
-0.10
2.83%
At close Oct 17, 4:00 PM EDT
1 day
-2.83%
5 days
3.31%
1 month
-6.28%
3 months
-43.59%
6 months
-38.64%
Year to date
-65.42%
1 year
-41.67%
5 years
-93.00%
 

About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Employees: 230

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

178% more call options, than puts

Call options by funds: $89K | Put options by funds: $32K

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

20% more funds holding

Funds holding: 75 [Q1] → 90 (+15) [Q2]

8% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 25

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

6.54% less ownership

Funds ownership: 63.09% [Q1] → 56.55% (-6.54%) [Q2]

36% less capital invested

Capital invested by funds: $157M [Q1] → $100M (-$56.3M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$12
250%
upside
Avg. target
$12
250%
upside
High target
$12
250%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Leerink Partners
250%upside
$12
Outperform
Maintained
17 Oct 2024

Financial journalist opinion

Charts implemented using Lightweight Charts™